The role of lncRNA binding to RNA‑binding proteins to regulate mRNA stability in cancer progression and drug resistance mechanisms (Review)

Erber J and Herndler-Brandstetter D: Regulation of T cell differentiation and function by long noncoding RNAs in homeostasis and cancer. Front Immunol. 14:11814992023. View Article : Google Scholar : PubMed/NCBI

Liu X, Li Y, Jiang X, Deng Y, Ma C, Yu Q and Gao D: Long non-coding RNA: Multiple effects on the differentiation, maturity and cell function of dendritic cells. Clin Immunol. 245:1091672022. View Article : Google Scholar : PubMed/NCBI

Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, Chen R, Dean C, Dinger ME, Fitzgerald KA, et al: Long non-coding RNAs: Definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 24:430–447. 2023. View Article : Google Scholar : PubMed/NCBI

Fan J, Li H, Xie R, Zhang X, Nie X, Shi X, Zhan J, Yin Z, Zhao Y, Dai B, et al: LncRNA ZNF593-AS alleviates contractile dysfunction in dilated cardiomyopathy. Circ Res. 128:1708–1723. 2021. View Article : Google Scholar : PubMed/NCBI

Huang H, Yan J, Lan X, Guo Y, Sun M, Zhao Y, Zhang F, Sun J and Lu S: LncRNA WDR11-AS1 promotes extracellular matrix synthesis in osteoarthritis by directly interacting with RNA-binding protein PABPC1 to stabilize SOX9 expression. Int J Mol Sci. 24:8172023. View Article : Google Scholar : PubMed/NCBI

Liu F, Cao Y, Zhang C and Su H: Decreased DANCR contributes to high glucose-induced extracellular matrix accumulation in human renal mesangial cell via regulating the TGF-β/Smad signaling. FASEB J. 37:e229262023. View Article : Google Scholar : PubMed/NCBI

Yang Z, Wan J, Ma L, Li Z, Yang R, Yang H, Li J, Zhou F and Ming L: Long non-coding RNA HOXC-AS1 exerts its oncogenic effects in esophageal squamous cell carcinoma by interaction with IGF2BP2 to stabilize SIRT1 expression. J Clin Lab Anal. 37:e248012023. View Article : Google Scholar : PubMed/NCBI

Cai Z, Shi Q, Li Y, Jin L, Li S, Wong LL, Wang J, Jiang X, Zhu M, Lin J, et al: LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein. Sci Adv. 9:eadi38212023. View Article : Google Scholar : PubMed/NCBI

Liu M, Li H, Li X, Pan B, Zhang J, Pan Y, Shen M and Liu L: A novel lncRNA FUAT1/TNS4 axis confers chemoresistance by suppressing reactive oxygen species-mediated apoptosis in gastric cancer. Antioxid Redox Signal. 41:24–41. 2024. View Article : Google Scholar : PubMed/NCBI

Zheng Z, Wu M, Li H, Xu W, Yang M, Pan K, Ni Y, Jiang T, Zheng H, Jin X, et al: Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis. BMC Med. 21:1322023. View Article : Google Scholar : PubMed/NCBI

Bae H and Coller J: Codon optimality-mediated mRNA degradation: Linking translational elongation to mRNA stability. Mol Cell. 82:1467–1476. 2022. View Article : Google Scholar : PubMed/NCBI

Schuster SL, Arora S, Wladyka CL, Itagi P, Corey L, Young D, Stackhouse BL, Kollath L, Wu QV, Corey E, et al: Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3′ untranslated region mutations. Cell Rep. 42:1128402023. View Article : Google Scholar : PubMed/NCBI

Jia L, Mao Y, Ji Q, Dersh D, Yewdell JW and Qian SB: Decoding mRNA translatability and stability from the 5′ UTR. Nat Struct Mol Biol. 27:814–821. 2020. View Article : Google Scholar : PubMed/NCBI

Passmore LA and Coller J: Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression. Nat Rev Mol Cell Biol. 23:93–106. 2022. View Article : Google Scholar : PubMed/NCBI

Bednarek S, Madan V, Sikorski PJ, Bartenschlager R, Kowalska J and Jemielity J: mRNAs biotinylated within the 5′ cap and protected against decapping: New tools to capture RNA-protein complexes. Philos Trans R Soc Lond B Biol Sci. 373:201801672018. View Article : Google Scholar : PubMed/NCBI

Korn SM, Ulshöfer CJ, Schneider T and Schlundt A: Structures and target RNA preferences of the RNA-binding protein family of IGF2BPs: An overview. Structure. 29:787–803. 2021. View Article : Google Scholar : PubMed/NCBI

Mushtaq A, Mir US and Altaf M: Multifaceted functions of RNA-binding protein vigilin in gene silencing, genome stability, and autism-related disorders. J Biol Chem. 299:1029882023. View Article : Google Scholar : PubMed/NCBI

Yao ZT, Yang YM, Sun MM, He Y, Liao L, Chen KS and Li B: New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer. Cancer Commun (Lond). 42:117–140. 2022. View Article : Google Scholar : PubMed/NCBI

Li W, Deng X and Chen J: RNA-binding proteins in regulating mRNA stability and translation: Roles and mechanisms in cancer. Semin Cancer Biol. 86:664–677. 2022. View Article : Google Scholar : PubMed/NCBI

Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X and Zheng L: RNA-binding proteins in tumor progression. J Hematol Oncol. 13:902020. View Article : Google Scholar : PubMed/NCBI

Ouyang J, Zhong Y, Zhang Y, Yang L, Wu P, Hou X, Xiong F, Li X, Zhang S, Gong Z, et al: Long non-coding RNAs are involved in alternative splicing and promote cancer progression. Br J Cancer. 126:1113–1124. 2022. View Article : Google Scholar : PubMed/NCBI

Schmitt AM and Chang HY: Long noncoding RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI

Shaath H, Vishnubalaji R, Elango R, Kardousha A, Islam Z, Qureshi R, Alam T, Kolatkar PR and Alajez NM: Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches. Semin Cancer Biol. 86:325–345. 2022. View Article : Google Scholar : PubMed/NCBI

Ramesh-Kumar D and Guil S: The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer. Semin Cancer Biol. 86:18–31. 2022. View Article : Google Scholar : PubMed/NCBI

Miao W, Porter DF, Lopez-Pajares V, Siprashvili Z, Meyers RM, Bai Y, Nguyen DT, Ko LA, Zarnegar BJ, Ferguson ID, et al: Glucose dissociates DDX21 dimers to regulate mRNA splicing and tissue differentiation. Cell. 186:80–97.e26. 2023. View Article : Google Scholar : PubMed/NCBI

Gebauer F, Schwarzl T, Valcárcel J and Hentze MW: RNA-binding proteins in human genetic disease. Nat Rev Genet. 22:185–198. 2021. View Article : Google Scholar : PubMed/NCBI

Herman AB, Tsitsipatis D and Gorospe M: Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 82:2252–2266. 2022. View Article : Google Scholar : PubMed/NCBI

Nojima T and Proudfoot NJ: Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics. Nat Rev Mol Cell Biol. 23:389–406. 2022. View Article : Google Scholar : PubMed/NCBI

Knott GJ, Bond CS and Fox AH: The DBHS proteins SFPQ, NONO and PSPC1: A multipurpose molecular scaffold. Nucleic Acids Res. 44:3989–4004. 2016. View Article : Google Scholar : PubMed/NCBI

Chen Y, Lu Y, Yang L, Ma W, Dong Y, Zhou S, Liu N, Gan W and Li D: LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-TFE3 rearranged renal cell carcinoma in an NAD⁺ kinase-independent manner kinase-independent manner. J Exp Clin Cancer Res. 42:2522023. View Article : Google Scholar : PubMed/NCBI

Zhao P, Ji MM, Fang Y, Li X, Yi HM, Yan ZX, Cheng S, Xu PP, Janin A, Wang CF, et al: A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes. Cell Death Dis. 12:3212021. View Article : Google Scholar : PubMed/NCBI

Feng Y, Zhang T, Zhang Z, Liang Y, Wang H, Chen Y, Yu X, Song X, Mao Q, Xia W, et al: The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma. Cell Death Dis. 14:5512023. View Article : Google Scholar : PubMed/NCBI

Zhang W, Zhao J, Deng L, Ishimwe N, Pauli J, Wu W, Shan S, Kempf W, Ballantyne MD, Kim D, et al: INKILN is a novel long noncoding RNA promoting vascular smooth muscle inflammation via scaffolding MKL1 and USP10. Circulation. 148:47–67. 2023. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Zhang H, Zhang X and Liu B: CBR3-AS1 accelerates the malignant proliferation of gestational choriocarcinoma cells by stabilizing SETD4. Dis Markers. 2022:71555252022.PubMed/NCBI

Xie M, Ma T, Xue J, Ma H, Sun M, Zhang Z, Liu M, Liu Y, Ju S, Wang Z and De W: The long intergenic non-protein coding RNA 707 promotes proliferation and metastasis of gastric cancer by interacting with mRNA stabilizing protein HuR. Cancer Lett. 443:67–79. 2019. View Article : Google Scholar : PubMed/NCBI

Ni T, Guo D, Tan L, Xiao Z and Shi Y: NPSR1-AS1 activates the MAPK pathway to facilitate thyroid cancer cell malignant behaviors via recruiting ELAVL1 to stabilize NPSR1 mRNA. Cell Cycle. 21:439–449. 2022. View Article : Google Scholar : PubMed/NCBI

Jalali S, Gandhi S and Scaria V: Distinct and modular organization of protein interacting sites in long non-coding RNAs. Front Mol Biosci. 5:272018. View Article : Google Scholar : PubMed/NCBI

Wang C, Yang Y, Zhang G, Li J, Wu X, Ma X, Shan G and Mei Y: Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis. Proc Natl Acad Sci USA. 116:14620–14629. 2019. View Article : Google Scholar : PubMed/NCBI

Pan L, Li Y, Jin L, Li J and Xu A: TRPM2-AS promotes cancer cell proliferation through control of TAF15. Int J Biochem Cell Biol. 120:1056832020. View Article : Google Scholar : PubMed/NCBI

Wang L, Ye S, Wang J, Gu Z, Zhang Y, Zhang C and Ma X: HuR stabilizes lnc-Sox5 mRNA to promote tongue carcinogenesis. Biochemistry (Mosc). 82:438–445. 2017. View Article : Google Scholar : PubMed/NCBI

Wang A, Bao Y, Wu Z, Zhao T, Wang D, Shi J, Liu B, Sun S, Yang F, Wang L and Qu L: Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer. Cell Death Dis. 10:1542019. View Article : Google Scholar : PubMed/NCBI

Wu D, He X, Wang W, Hu X, Wang K and Wang M: Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1. Mol Oncol. 14:2332–2351. 2020. View Article : Google Scholar : PubMed/NCBI

Chen B, Xu X, Wu W, Zheng K and Yu Y: LINC00659 inhibits hepatocellular carcinoma malignant progression by blocking aerobic glycolysis through FUS recruitment and SLC10A1 modulation. Anal Cell Pathol (Amst). 2023:58529632023.PubMed/NCBI

Tuo H, Liu R, Wang Y, Yang W and Liu Q: Hypoxia-induced lncRNA MRVI1-AS1 accelerates hepatocellular carcinoma progression by recruiting RNA-binding protein CELF2 to stabilize SKA1 mRNA. World J Surg Oncol. 21:1112023. View Article : Google Scholar : PubMed/NCBI

Tian C, Abudoureyimu M, Lin X, Chu X and Wang R: Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression. Cell Death Dis. 12:10472021. View Article : Google Scholar : PubMed/NCBI

Ren L, Fang X, Shrestha SM, Ji Q, Ye H, Liang Y, Liu Y, Feng Y, Dong J and Shi R: LncRNA SNHG16 promotes development of oesophageal squamous cell carcinoma by interacting with EIF4A3 and modulating RhoU mRNA stability. Cell Mol Biol Lett. 27:892022. View Article : Google Scholar : PubMed/NCBI

Yang Z and Hu T: Long noncoding RNA HOXC-AS3 facilitates the progression of invasive mucinous adenocarcinomas of the lung via modulating FUS/FOXM1. In Vitro Cell Dev Biol Anim. 56:15–23. 2020. View Article : Google Scholar : PubMed/NCBI

Zhu L, Liu Y, Tang H and Wang P: FOXP3 activated-LINC01232 accelerates the stemness of non-small cell lung carcinoma by activating TGF-β signaling pathway and recruiting IGF2BP2 to stabilize TGFBR1. Exp Cell Res. 413:1130242022. View Article : Google Scholar : PubMed/NCBI

Yang F, Xue X, Zheng L, Bi J, Zhou Y, Zhi K, Gu Y and Fang G: Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability. FEBS J. 281:802–813. 2014. View Article : Google Scholar : PubMed/NCBI

Luo N, Zhang K, Li X and Hu Y: ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA. J Cell Biochem. 121:4176–4187. 2020. View Article : Google Scholar : PubMed/NCBI

Ning X, Zhao J, He F, Yuan Y, Li B and Ruan J: lncRNA NUTM2A-AS1 targets the SRSF1/Trim37 signaling pathway to promote the proliferation and invasion of breast cancer. Comput Math Methods Med. 2022:32993362022. View Article : Google Scholar : PubMed/NCBI

Wen D, Huang Z, Li Z, Tang X, Wen X, Liu J and Li M: LINC02535 co-functions with PCBP2 to regulate DNA damage repair in cervical cancer by stabilizing RRM1 mRNA. J Cell Physiol. 235:7592–7603. 2020. View Article : Google Scholar : PubMed/NCBI

Wang L, Ruan Y, Wu X and Zhou X: lncRNA ZFAS1 promotes HMGCR mRNA stabilization via binding U2AF2 to modulate pancreatic carcinoma lipometabolism. J Immunol Res. 2022:41631982022. View Article : Google Scholar : PubMed/NCBI

Chen R, Zhang X and Wang C: LncRNA HOXB-AS1 promotes cell growth in multiple myeloma via FUT4 mRNA stability by ELAVL1. J Cell Biochem. 121:4043–4051. 2020. View Article : Google Scholar : PubMed/NCBI

Lu X, Qiao L and Liu Y: Long noncoding RNA LEF1-AS1 binds with HNRNPL to boost the proliferation, migration, and invasion in osteosarcoma by enhancing the mRNA stability of LEF1. J Cell Biochem. 121:4064–4073. 2020. View Article : Google Scholar : PubMed/NCBI

Zhang M, Sun Y, Huang CP, Luo J, Zhang L, Meng J, Liang C and Chang C: Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases enzalutamide sensitivity to better suppress prostate cancer progression. Cell Death Dis. 12:8552021. View Article : Google Scholar : PubMed/NCBI

Dos Santos AF, Fazeli G, Xavier da Silva TN and Friedmann Angeli JP: Ferroptosis: Mechanisms and implications for cancer development and therapy response. Trends Cell Biol. 33:1062–1076. 2023. View Article : Google Scholar : PubMed/NCBI

Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al: Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI

Tang D, Chen X, Kang R and Kroemer G: Ferroptosis: Molecular mechanisms and health implications. Cell Res. 31:107–125. 2021. View Article : Google Scholar : PubMed/NCBI

Jiang X, Stockwell BR and Conrad M: Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI

Qi R, Bai Y, Li K, Liu N, Xu Y, Dal E, Wang Y, Lin R, Wang H, Liu Z, et al: Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resist Updat. 68:1009602023. View Article : Google Scholar : PubMed/NCBI

Zhang Q, Deng T, Zhang H, Zuo D, Zhu Q, Bai M, Liu R, Ning T, Zhang L, Yu Z, et al: Adipocyte-derived exosomal MTTP suppresses ferroptosis and promotes chemoresistance in colorectal cancer. Adv Sci (Weinh). 9:e22033572022. View Article : Google Scholar : PubMed/NCBI

Zhang C, Liu X, Jin S, Chen Y and Guo R: Ferroptosis in cancer therapy: A novel approach to reversing drug resistance. Mol Cancer. 21:472022. View Article : Google Scholar : PubMed/NCBI

Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J and Wang H: Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat. 66:1009162023. View Article : Google Scholar : PubMed/NCBI

Luo J, Bai R, Liu Y, Bi H, Shi X and Qu C: Long non-coding RNA ATXN8OS promotes ferroptosis and inhibits the temozolomide-resistance of gliomas through the ADAR/GLS2 pathway. Brain Res Bull. 186:27–37. 2022. View Article : Google Scholar : PubMed/NCBI

Gowravaram M, Schwarz J, Khilji SK, Urlaub H and Chakrabarti S: Insights into the assembly and architecture of a Staufen-mediated mRNA decay (SMD)-competent mRNP. Nat Commun. 10:50542019. View Article : Google Scholar : PubMed/NCBI

Yadav DK, Zigáčková D, Zlobina M, Klumpler T, Beaumont C, Kubíčková M, Vaňáčová Š and Lukavsky PJ: Staufen1 reads out structure and sequence features in ARF1 dsRNA for target recognition. Nucleic Acids Res. 48:2091–2106. 2020. View Article : Google Scholar : PubMed/NCBI

Lu D, Di S, Zhuo S, Zhou L, Bai R, Ma T, Zou Z, Chen C, Sun M, Tang J and Zhang Z: The long noncoding RNA TINCR promotes breast cancer cell proliferation and migration by regulating OAS1. Cell Death Discov. 7:412021. View Article : Google Scholar : PubMed/NCBI

Zhao L, Jiang L, Zhang M, Zhang Q, Guan Q, Li Y, He M, Zhang J and Wei M: NF-κB-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating TCEB1 mRNA via Staufen1-mediated mRNA decay. Oncogene. 40:4919–4929. 2021. View Article : Google Scholar : PubMed/NCBI

Eken JA, Koning MT, Kupcova K, Sepúlveda Yáñez JH, de Groen RAL, Quinten E, Janssen J, van Bergen CAM, Vermaat JSP, Cleven A, et al: Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL. J Exp Med. 221:e202309412024. View Article : Google Scholar : PubMed/NCBI

Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, et al: Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 378:1396–1407. 2018. View Article : Google Scholar : PubMed/NCBI

Liu QH, Dai GR, Wu Y, Wang XN, Song MY, Li XD, Wu Z and Xia RX: LncRNA FIRRE stimulates PTBP1-induced Smurf2 decay, stabilizes B-cell receptor, and promotes the development of diffuse large B-cell lymphoma. Hematol Oncol. 40:554–566. 2022. View Article : Google Scholar : PubMed/NCBI

Nag S, Goswami B, Das Mandal S and Ray PS: Cooperation and competition by RNA-binding proteins in cancer. Semin Cancer Biol. 86:286–297. 2022. View Article : Google Scholar : PubMed/NCBI

Liu Y, Xue M, Du S, Feng W, Zhang K, Zhang L, Liu H, Jia G, Wu L, Hu X, et al: Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT. Nat Commun. 10:16372019. View Article : Google Scholar : PubMed/NCBI

Zhou L, Jiang J, Huang Z, Jin P, Peng L, Luo M, Zhang Z, Chen Y, Xie N, Gao W, et al: Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m⁶A-mediated degradation of STEAP3 mRNA. Mol Cancer. 21:1682022. View Article : Google Scholar : PubMed/NCBI

Tao W, Ma J, Zheng J, Liu X, Liu Y, Ruan X, Shen S, Shao L, Chen J and Xue Y: Silencing SCAMP1-TV2 inhibited the malignant biological behaviors of breast cancer cells by interaction with PUM2 to facilitate INSM1 mRNA degradation. Front Oncol. 10:6132020. View Article : Google Scholar : PubMed/NCBI

Wang H, Ma P, Liu P, Guo D, Liu Z and Zhang Z: lncRNA SNHG6 promotes hepatocellular carcinoma progression by interacting with HNRNPL/PTBP1 to facilitate SETD7/LZTFL1 mRNA destabilization. Cancer Lett. 520:121–131. 2021. View Article : Google Scholar : PubMed/NCBI

He J, Zuo Q, Hu B, Jin H, Wang C, Cheng Z, Deng X, Yang C, Ruan H, Yu C, et al: A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Lett. 450:98–109. 2019. View Article : Google Scholar : PubMed/NCBI

Puertollano R, Ferguson SM, Brugarolas J and Ballabio A: The complex relationship between TFEB transcription factor phosphorylation and subcellular localization. EMBO J. 37:e988042018. View Article : Google Scholar : PubMed/NCBI

Shen Y, Zou Y, Li J, Chen F, Li H and Cai Y: CDK5RAP3, a novel nucleoplasmic shuttle, deeply regulates hsf1-mediated heat stress response and protects mammary epithelial cells from heat injury. Int J Mol Sci. 21:84002020. View Article : Google Scholar : PubMed/NCBI

Chen J, Liu L, Wei G, Wu W, Luo H, Yuan J, Luo J and Chen R: The long noncoding RNA ASNR regulates degradation of Bcl-2 mRNA through its interaction with AUF1. Sci Rep. 6:321892016. View Article : Google Scholar : PubMed/NCBI

Wang Y, Li Z, Xu S, Li W, Chen M, Jiang M and Fan X: LncRNA FIRRE functions as a tumor promoter by interaction with PTBP1 to stabilize BECN1 mRNA and facilitate autophagy. Cell Death Dis. 13:982022. View Article : Google Scholar : PubMed/NCBI

He PC, Wei J, Dou X, Harada BT, Zhang Z, Ge R, Liu C, Zhang LS, Yu X, Wang S, et al: Exon architecture controls mRNA m⁶A suppression and gene expression. Science. 379:677–682. 2023. View Article : Google Scholar : PubMed/NCBI

Deng X, Qing Y, Horne D, Huang H and Chen J: The roles and implications of RNA m⁶A modification in cancer. Nat Rev Clin Oncol. 20:507–526. 2023. View Article : Google Scholar : PubMed/NCBI

Uzonyi A, Dierks D, Nir R, Kwon OS, Toth U, Barbosa I, Burel C, Brandis A, Rossmanith W, Le Hir H, et al: Exclusion of m6A from splice-site proximal regions by the exon junction complex dictates m6A topologies and mRNA stability. Mol Cell. 83:237–251.e7. 2023. View Article : Google Scholar : PubMed/NCBI

Chen J, Zhang H, Xiu C, Gao C, Wu S, Bai J, Shen Q and Yin T: METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner. Cancer Lett. 565:2162222023. View Article : Google Scholar : PubMed/NCBI

Fagre C and Gilbert W: Beyond reader proteins: RNA binding proteins and RNA modifications in conversation to regulate gene expression. Wiley Interdiscip Rev RNA. 15:e18342024. View Article : Google Scholar : PubMed/NCBI

Elcheva IA, Gowda CP, Bogush D, Gornostaeva S, Fakhardo A, Sheth N, Kokolus KM, Sharma A, Dovat S, Uzun Y, et al: IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment. Front Immunol. 14:12245162023. View Article : Google Scholar : PubMed/NCBI

Stowell JAW, Webster MW, Kögel A, Wolf J, Shelley KL and Passmore LA: Reconstitution of targeted deadenylation by the Ccr4-not complex and the YTH domain protein Mmi1. Cell Rep. 17:1978–1989. 2016. View Article : Google Scholar : PubMed/NCBI

Sikorski V, Selberg S, Lalowski M, Karelson M and Kankuri E: The structure and function of YTHDF epitranscriptomic m⁶A readers. Trends Pharmacol Sci. 44:335–353. 2023. View Article : Google Scholar : PubMed/NCBI

Yang J, Qian X, Qiu Q, Xu L, Pan M, Li J, Ren J, Lu B, Qiu T, Chen E, et al: LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis. Cell Death Dis. 13:8772022. View Article : Google Scholar : PubMed/NCBI

Zhu P, He F, Hou Y, Tu G, Li Q, Jin T, Zeng H, Qin Y, Wan X, Qiao Y, et al: A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability. Oncogene. 40:1609–1627. 2021. View Article : Google Scholar : PubMed/NCBI

Wang Y and Chen Z: Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA. Bioengineered. 13:178–189. 2022. View Article : Google Scholar : PubMed/NCBI

Yang H, Hu Y, Weng M, Liu X, Wan P, Hu Y, Ma M, Zhang Y, Xia H and Lv K: Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer. J Adv Res. 37:91–106. 2021. View Article : Google Scholar : PubMed/NCBI

Afrin H, Geetha Bai R, Kumar R, Ahmad SS, Agarwal SK and Nurunnabi M: Oral delivery of RNAi for cancer therapy. Cancer Metastasis Rev. 42:699–724. 2023. View Article : Google Scholar : PubMed/NCBI

Chan YT, Lu Y, Wu J, Zhang C, Tan HY, Bian ZX, Wang N and Feng Y: CRISPR-Cas9 library screening approach for anti-cancer drug discovery: Overview and perspectives. Theranostics. 12:3329–3344. 2022. View Article : Google Scholar : PubMed/NCBI

Fan J, Xu Y, Wen X, Ge S, Jia R, Zhang H and Fan X: A cohesin-mediated intrachromosomal loop drives oncogenic ROR lncRNA to accelerate tumorigenesis. Mol Ther. 27:2182–2194. 2019. View Article : Google Scholar : PubMed/NCBI

Wang R, Sun Y, Li L, Niu Y, Lin W, Lin C, Antonarakis ES, Luo J, Yeh S and Chang C: Preclinical study using Malat1 small interfering RNA or androgen receptor splicing variant 7 degradation enhancer ASC-J9^® to suppress enzalutamide-resistant prostate cancer progression. Eur Urol. 72:835–844. 2017. View Article : Google Scholar : PubMed/NCBI

Wu X, Ramesh R, Wang J, Zheng Y, Armaly AM, Wei L, Xing M, Roy S, Lan L, Gao FP, et al: Small molecules targeting the RNA-binding protein HuR inhibit tumor growth in xenografts. J Med Chem. 66:2032–2053. 2023. View Article : Google Scholar : PubMed/NCBI

Weng H, Huang F, Yu Z, Chen Z, Prince E, Kang Y, Zhou K, Li W, Hu J, Fu C, et al: The m⁶A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 40:1566–1582.e10. 2022. View Article : Google Scholar : PubMed/NCBI

Xu F, Li J, Ni M, Cheng J, Zhao H, Wang S, Zhou X and Wu X: FBW7 suppresses ovarian cancer development by targeting the N⁶-methyladenosine binding protein YTHDF2. Mol Cancer. 20:452021. View Article : Google Scholar : PubMed/NCBI

Katsushima K, Lee B, Kunhiraman H, Zhong C, Murad R, Yin J, Liu B, Garancher A, Gonzalez-Gomez I, Monforte HL, et al: The long noncoding RNA lnc-HLX-2-7 is oncogenic in group 3 medulloblastomas. Neuro Oncol. 23:572–585. 2021. View Article : Google Scholar : PubMed/NCBI